Nasal spray vaccine aims to protect kids from RSV
NCT ID NCT01893554
First seen May 17, 2026 · Last updated May 17, 2026
Summary
This study tested a new RSV vaccine given as nose drops to 88 children aged 4 months to 5 years. The vaccine uses a weakened live virus to safely teach the immune system to fight RSV. Researchers monitored side effects and measured antibody levels to see if the vaccine triggers protection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY SYNCYTIAL VIRUS INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Center for Immunization Research (CIR)
Baltimore, Maryland, 21205, United States
-
Center for Immunization Research South
Laurel, Maryland, 20708, United States
Conditions
Explore the condition pages connected to this study.